title: Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: preliminary results.
authors.forename: Paolo
authors.initials: P
authors.lastname: Anderlini
authors.forename: Rima M
authors.initials: RM
authors.lastname: Saliba
authors.forename: Celina
authors.initials: C
authors.lastname: Ledesma
authors.forename: Christina
authors.initials: C
authors.lastname: Chancoco
authors.forename: Amin M
authors.initials: AM
authors.lastname: Alousi
authors.forename: Elizabeth J
authors.initials: EJ
authors.lastname: Shpall
authors.forename: Uday R
authors.initials: UR
authors.lastname: Popat
authors.forename: Chitra M
authors.initials: CM
authors.lastname: Hosing
authors.forename: Issa F
authors.initials: IF
authors.lastname: Khouri
authors.forename: Yago
authors.initials: Y
authors.lastname: Nieto
authors.forename: Stefan
authors.initials: S
authors.lastname: Ciurea
authors.forename: Anas
authors.initials: A
authors.lastname: Younes
authors.forename: Michelle A
authors.initials: MA
authors.lastname: Fanale
authors.forename: Sandra
authors.initials: S
authors.lastname: Acholonu
authors.forename: Rosamar
authors.initials: R
authors.lastname: Valverde
authors.forename: Richard E
authors.initials: RE
authors.lastname: Champlin
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy / Q000601:surgery*; D006801:Humans; D053208:Kaplan-Meier Estimate; D008297:Male; D008558:Melphalan / Q000008:administration & dosage; D008875:Middle Aged; D012008:Recurrence; D012074:Remission Induction; D016879:Salvage Therapy; D033581:Stem Cell Transplantation; D019172:Transplantation Conditioning / Q000379:methods*; D014184:Transplantation, Homologous; D016896:Treatment Outcome; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives; D055815:Young Adult; D000093542:Gemcitabine
chemical_list: D003841:Deoxycytidine; D014740:Vidarabine; C024352:fludarabine; D008558:Melphalan; D000093542:Gemcitabine